Schonfeld Strategic Advisors’s Eli Lilly LLY Stock Holding History

Schonfeld Strategic Advisors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.84M	Hold	2,000	–	–	0.01%	863
2025 Q4	$2.15M	Buy	+2,000	New	+$1.91M	0.01%	851
2025 Q2	–	Sell	-6,600	Closed	-$5.45M	–	2319
2025 Q1	$5.45M	Buy	+6,600	New	+$5.49M	0.03%	499
2024 Q2	–	Sell	-700	Closed	-$545K	–	2382
2024 Q1	$545K	Buy	+700	New	+$498K	﹤0.01%	1452
2023 Q3	–	Sell	-25,000	Closed	-$635K	–	2059
2023 Q2	$635K	Buy	+25,000	New	+$10.5M	0.01%	1128

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Schonfeld Strategic Advisors's LLY Position: Q1 2026 in Review

Schonfeld Strategic Advisors increased its Eli Lilly (LLY) stake by 6,059% in Q1 2026, buying an estimated $26.2M and bringing the position to 26,237 shares worth $24.1M. The position accounts for 0.17% of the portfolio, ranked #116.

Schonfeld Strategic Advisors first reported a position in LLY in Q4 2016 and has held it in 29 quarters since. The position peaked at $74.1M in Q2 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Schonfeld Strategic Advisors held 26,237 shares of Eli Lilly worth $24.1M as of Q1 2026.
Schonfeld Strategic Advisors bought 25,811 Eli Lilly shares in Q1 2026, an estimated $26.2M.
Eli Lilly made up 0.17% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #116 holding.
Schonfeld Strategic Advisors first reported a position in Eli Lilly in Q4 2016 and has held it in 29 quarters since.
Schonfeld Strategic Advisors's Eli Lilly position peaked at $74.1M in Q2 2025.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.